A 2019 ruling by the Internal Revenue Service* means that you should be able to use funds set aside in either a Flexible Spending Account (FSA) or Health Savings Account (HSA) to cover all or a portion of the medical care costs of the 23andMe services listed below.
Check with your FSA/HSA benefits coordinator or your tax professional for confirmation on the specific requirements for individual eligibility and reimbursement, including usage, procedures and qualifications.
- 23andMe+ Total Health™ Bundle**
- 23andMe+ Total Health Membership**
- 23andMe+ Premium™ Bundle***
- 23andMe+ Premium Membership**
- Health + Ancestry Service***
- Health Service** (only available on Amazon, Walmart.com or FSAStore.com/HSAStore.com)
- Upgrade to 23andMe+ Total Health (for customers who originally purchased the 23andMe+ Premium Bundle, Health + Ancestry Service, or Ancestry Service)**
- Upgrade to 23andMe+ Premium (for customers who originally purchased the Health + Ancestry Service or Ancestry Service)**
- Upgrade to Health + Ancestry Service (for customers who originally purchased the 23andMe Ancestry Service)**
- Health + Ancestry Service lab fee (for customers who purchased their saliva collection kit from an authorized retailer, such as CVS, Walgreens, Walmart, but who purchased the Health + Ancestry Service from 23andMe)***
- Health + Ancestry Service chip upgrade (for customers who purchased a new kit to be genotyped on the latest platform)***
Additionally, clinical laboratory testing fees and telehealth/telemedicine clinical consultation fees should be eligible for reimbursement with an FSA or HSA.
To determine the amount of your 23andMe purchase that may be eligible medical care, and to obtain a receipt to submit with your original purchase receipt for your FSA/HSA claim, complete this form for each item that you purchased. If you purchased more than one item that may be FSA/HSA-eligible, submit information for each item into this form one at a time.
23andMe+ Total Health, 23andMe+ Premium, and the Health + Ancestry Service can be purchased through our online 23andMe store.
Common Questions
How much of my Health + Ancestry Service purchase is FSA/HSA eligible?
In general, the Health component of the Health + Ancestry Service should be eligible as medical care covered by your FSA/HSA benefit during the year the purchase was made. The Health component of the Health + Ancestry Service consists of testing services and reports subject to FDA jurisdiction, including the Health Predisposition†, Carrier Status† and Wellness Reports. The Health component of the Health + Ancestry Service, valued at ~$164 + shipping and tax (where applicable) should be eligible as medical care covered by your FSA/HSA benefit (based on regular price of $199).
For purchases of the Health + Ancestry Service in a prior year:
FSA benefits can only be used to reimburse medical care expenses, including the Health + Ancestry Service, during the current plan year of your FSA plan. Purchases made in prior years will be ineligible, though your plan may have a grace period extending from the prior year into the current year (consult your administrator if you have questions).
The Health component of a prior purchase of the Health + Ancestry Service may be eligible as medical care covered by your HSA benefit, if the purchase was made while you held your current HSA account. The Health component of the Health + Ancestry Service consists of testing services and reports subject to FDA jurisdiction, including the Health Predisposition†, Carrier Status† and Wellness Reports. The Health Predisposition†, Carrier Status† and Wellness Reports should be eligible as medical care covered by your HSA benefit. 23andMe does not charge separately for Traits Reports, but provides them as part of the Health component.
How much of my Health Service purchase is FSA/HSA eligible?
The entire cost of the Health Service is eligible as medical care covered by your FSA/HSA benefit. The Health Service consists of testing services and reports subject to FDA jurisdiction, including the Health Predisposition†, Carrier Status†, and Wellness Reports. FSA benefits can only be used to reimburse medical care expenses, including the Health Service, during the current plan year of your FSA plan. Purchases made in prior years will be ineligible, though your plan may have a grace period extending from the prior year into the current year (consult your administrator if you have questions).
Is my 23andMe+ Premium annual membership fee FSA/HSA eligible?
In general the annual fee for the 23andMe+ Premium Annual Membership should be eligible as medical care covered by your FSA/HSA benefit during the year the purchase was made.
23andMe+ Premium membership includes access to premium reports and features delivered throughout the year. Reports include:
- FDA authorized health reports
- Polygenic reports, which look at your genetic likelihood for more common conditions like LDL Cholesterol, Asthma and Anxiety
Pharmacogenetics reports‡, which help you understand how your genetics can impact how you process certain types of medications
Is my 23andMe+ Total Health annual membership fee FSA/HSA eligible?
In general the annual fee for the 23andMe+ Total Health Annual Membership should be eligible as medical care covered by your FSA/HSA benefit during the year the purchase was made.
23andMe+ Total Health is a new, first-of-its-kind health membership that combines exome sequencing, blood testing and direct access to clinical services. Members will get personalized recommendations with a focus on ongoing disease prevention and early detection. The service includes:
-
Exome sequencing: Clinician-ordered advanced genetic testing that screens for clinically actionable and under-diagnosed conditions
- Includes report categories for hereditary conditions related to cancer, cardiovascular, metabolic, kidney, neurological and other hereditary disease
- Includes all genes considered medically actionable by the American College of Medical Genetics (ACMG)
-
Bi-annual blood testing: Provides advanced cardiometabolic biomarkers plus insights into your thyroid, liver, kidneys and more
- Assesses 55+ biomarkers
- Initiated by a clinician and offered at local Quest Diagnostics patient service centers; results will be tracked and delivered within 23andMe’s platform
- Access to clinicians with unique knowledge and training in genetics-based care: Ongoing direct messaging, plus a dedicated virtual consultation annually with a genetics-trained clinician to help build and progress a personalized preventive health plan
-
Includes 23andMe+ Premium membership: Access to premium reports and features delivered throughout the year. Reports include:
- FDA authorized health reports
- Polygenic reports, which look at your genetic likelihood for more common conditions like LDL Cholesterol, Asthma and Anxiety
- Pharmacogenetics reports‡, which help you understand how your genetics can impact how you process certain types of medications
What if I purchased the Health + Ancestry Service at a discount? How much of my purchase is eligible?
The simplest way to determine the amount that should be eligible as medical care is to use the 23andMe FSA/HSA calculator.
For a discounted Health + Ancestry Service kit, our calculator will take the same percentage of the full Health + Ancestry Service kit price (retail $199) from what you otherwise would have been able to claim as eligible medical care on the full price service.
For example, if you paid $149 for the Health + Ancestry Service, then up to $122.97 + shipping and tax (where applicable) should be eligible medical care. This reflects application of the percentage discount off the Health + Ancestry Service to the amount that is eligible medical care where a customer pays the retail price of $199.
For the VIP Health + Ancestry Service, please contact Customer Care to determine the amount that should be eligible as medical care. Note, the VIP Health + Ancestry Service is no longer available for purchase as of January 19, 2021.
Can I use my FSA/HSA funds to buy the 23andMe+ Total Health Bundle, 23andMe+ Premium Bundle, Health + Ancestry Service and/or the Health Service for someone else?
Generally, FSA and HSA funds can be used by the account owner for eligible medical care expenses for them/their eligible dependents. If you are the account owner, eligible medical care expenses typically include those incurred by the following persons:
- You and your spouse
- Dependents you claim on your tax return
I bought a saliva collection kit in a store and then paid the lab processing fee separately online at 23andme.com to receive the Health + Ancestry Service. What is FSA/HSA eligible?
If you purchased the saliva collection kit - or have received such a kit as a gift - separate from selecting your service and paying a lab processing fee online, 23andMe can only provide you with a receipt for the lab processing fee as potentially eligible as medical care.
The simplest way to determine the amount that should be eligible as medical care is to use our 23andMe FSA/HSA calculator.
In general, the Health component of the Health + Ancestry Service lab processing fee should be eligible as medical care covered by your FSA/HSA benefit.
If I upgrade my 23andMe account from the Ancestry Service to the Health + Ancestry Service, what amount is FSA/HSA eligible?
Where you already have the 23andMe Ancestry Service and upgrade to receive our health reports, all of your upgrade fee should be considered eligible medical care.
The simplest way to determine the amount that should be eligible for medical care is to use our 23andMe FSA/HSA calculator. In general, the Health component of the Health + Ancestry Service should be eligible as medical care covered by your FSA/HSA benefit.
How do I get a receipt to submit to my FSA/HSA benefits administrator?
We’ll email you a receipt with your purchase confirmation. Include a copy of your calculation from the 23andMe FSA/HSA Calculator that details the amount that should be eligible medical care based on your valuation of the health reports and medical information included in the 23andMe service you purchased.
Can I use my FSA/HSA funds to pay for additional purchases of the Health + Ancestry Service or Health Service?
FSA/HSA administrators may allow you to use your FSA/HSA funds to cover qualified medical expenses for you and any person claimed as a dependent on your tax return. Check with your FSA/HSA benefits coordinator or your tax professional for confirmation on the specific requirements for individual eligibility and reimbursement, including usage, procedures, and qualifications.
*Ruling available here.
**Purchase may be eligible for Flexible Spending Account (FSA) and Health Savings Account (HSA) reimbursement.
***A portion of your purchase may be eligible for FSA/HSA reimbursement.
†The 23andMe PGS test includes health predisposition and carrier status reports. 23andMe health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. The Late-onset Alzheimer’s Disease genetic health risk report is indicated for reporting of the ε4 variant in the APOE gene and describes if a person has a variant associated with an increased risk of developing late-onset Alzheimer’s disease. The ε4 variant included in this report is found and has been studied in many ethnicities. Detailed risk estimates have been studied the most in people of European descent. The Parkinson’s Disease genetic health risk report is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene and describes if a person has variants associated with an increased risk of developing Parkinson’s disease. The variants included in this report are most common and best studied in people of European, Ashkenazi Jewish, and North African Berber descent. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/.
‡23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetic reports, visit 23andme.com/test-info/pharmacogenetics/